Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRKL
3301
DELISTED
Brookline Bancorp
BRKL
| $3.34M | ﹤0.01% |
218,907
+61,964
| +39% | +$899K |
|
|
ARBK
3302
Argo Blockchain
ARBK
$42M
| $3.34M | ﹤0.01% |
+966
| New | +$3.38M |
|
|
HLMNW
3303
CALL
DELISTED
Hillman Solutions Corp. Warrant
HLMNW
| $3.34M | ﹤0.01% |
1,151,666
+225,000
| +24% | +$684K |
|
3304
UBS Group
UBS
$168B
| $3.33M | ﹤0.01% |
209,214
-511,045
| -71% | -$8.28M |
|
3305
AerCap
AER
$23.2B
| $3.33M | ﹤0.01% |
57,581
+47,967
| +499% | +$2.57M |
|
3306
Regency Centers
REG
$13.8B
| $3.32M | ﹤0.01% |
49,358
-201,964
| -80% | -$13.4M |
|
|
DHHCU
3307
DELISTED
DiamondHead Holdings Corp. Unit
DHHCU
| $3.31M | ﹤0.01% |
334,001
-466,768
| -58% | -$4.63M |
|
3308
Idacorp
IDA
$7.85B
| $3.29M | ﹤0.01% |
31,850
+19,016
| +148% | +$1.99M |
|
|
FRSG
3309
DELISTED
First Reserve Sustainable Growth Corp. Class A Common Stock
FRSG
| $3.29M | ﹤0.01% |
334,668
-339,373
| -50% | -$3.32M |
|
3310
Assurant
AIZ
$14.1B
| $3.29M | ﹤0.01% |
20,855
-5,382
| -21% | -$869K |
|
|
SAND
3311
DELISTED
Sandstorm Gold
SAND
| $3.29M | ﹤0.01% |
+570,666
| New | +$3.94M |
|
3312
Grupo Aeroportuario Centro Norte
OMAB
$4.86B
| $3.29M | ﹤0.01% |
+70,111
| New | +$3.4M |
|
3313
NMI Holdings
NMIH
$3.37B
| $3.28M | ﹤0.01% |
145,071
-273,133
| -65% | -$6.01M |
|
|
SEE
3314
DELISTED
Sealed Air
SEE
| $3.27M | ﹤0.01% |
59,728
+34,500
| +137% | +$2M |
|
|
HCII
3315
DELISTED
Hudson Executive Investment Corp. II Class A Common Stock
HCII
| $3.27M | ﹤0.01% |
335,370
+83,428
| +33% | +$812K |
|
3316
CarMax
KMX
$8.81B
| $3.27M | ﹤0.01% |
25,526
-29,495
| -54% | -$3.93M |
|
|
NRAC
3317
DELISTED
Northern Revival Acquisition Corporation Class A Ordinary Share
NRAC
| $3.26M | ﹤0.01% |
336,088
+194,994
| +138% | +$1.89M |
|
3318
ResMed
RMD
$34.7B
| $3.26M | ﹤0.01% |
12,373
-193,308
| -94% | -$52.9M |
|
|
AMPI.U
3319
DELISTED
Advanced Merger Partners Inc Units
AMPI.U
| $3.26M | ﹤0.01% |
330,142
-93,664
| -22% | -$926K |
|
|
HMHC
3320
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $3.26M | ﹤0.01% |
242,675
-101,106
| -29% | -$1.27M |
|
3321
Neuropace
NPCE
$495M
| $3.26M | ﹤0.01% |
205,446
-48,792
| -19% | -$1.02M |
|
|
IBER
3322
DELISTED
Ibere Pharmaceuticals
IBER
| $3.26M | ﹤0.01% |
335,990
+104,000
| +45% | +$1.01M |
|
|
SEEL
3323
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $3.25M | ﹤0.01% |
352
-137
| -28% | -$1.18M |
|
|
SBEA
3324
DELISTED
SilverBox Engaged Merger Corp I Class A Common Stock
SBEA
| $3.25M | ﹤0.01% |
332,335
-397,221
| -54% | -$3.86M |
|
3325
Revvity
RVTY
$14.4B
| $3.25M | ﹤0.01% |
18,750
-134,940
| -88% | -$23.8M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.